Canxia Xu

1.1k total citations
56 papers, 622 citations indexed

About

Canxia Xu is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Canxia Xu has authored 56 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 15 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Canxia Xu's work include Helicobacter pylori-related gastroenterology studies (30 papers), Eosinophilic Esophagitis (11 papers) and Cancer-related molecular mechanisms research (8 papers). Canxia Xu is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (30 papers), Eosinophilic Esophagitis (11 papers) and Cancer-related molecular mechanisms research (8 papers). Canxia Xu collaborates with scholars based in China, United States and Canada. Canxia Xu's co-authors include Xiaoming Liu, Hao Wu, Xiaoming Liu, Michael A. Hill, Huan Li, Renjie Gong, Zhenguo Liu, Yinjie Guo, Zhenguo Liu and Hong Hao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Canxia Xu

54 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Canxia Xu China 14 310 215 204 93 69 56 622
Miki Aihara Japan 9 310 1.0× 115 0.5× 201 1.0× 44 0.5× 68 1.0× 16 571
Nobumi Suzuki Japan 16 311 1.0× 303 1.4× 127 0.6× 94 1.0× 146 2.1× 49 806
Kathleen S. Cormier United States 6 150 0.5× 140 0.7× 140 0.7× 34 0.4× 43 0.6× 7 452
Ali Rıza Köksal Türkiye 12 163 0.5× 116 0.5× 74 0.4× 30 0.3× 45 0.7× 38 537
Ann Elisabet Østvik Norway 15 160 0.5× 175 0.8× 255 1.3× 51 0.5× 57 0.8× 26 676
Yuta Fuyuno Japan 10 200 0.6× 140 0.7× 68 0.3× 25 0.3× 177 2.6× 27 453
Bridie J. Goggins Australia 12 88 0.3× 205 1.0× 150 0.7× 69 0.7× 87 1.3× 15 512
Katsuyoshi Ando Japan 14 203 0.7× 154 0.7× 40 0.2× 32 0.3× 105 1.5× 75 501

Countries citing papers authored by Canxia Xu

Since Specialization
Citations

This map shows the geographic impact of Canxia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canxia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canxia Xu more than expected).

Fields of papers citing papers by Canxia Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Canxia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canxia Xu. The network helps show where Canxia Xu may publish in the future.

Co-authorship network of co-authors of Canxia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Canxia Xu. A scholar is included among the top collaborators of Canxia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Canxia Xu. Canxia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lu, Wei, Yun Hu, Shuyue Chen, et al.. (2025). Exosomal CagA induces macrophage polarization and ferroptosis by JAK1-2/STAT1 signaling pathway in Helicobacter pylori-associated gastritis. Free Radical Biology and Medicine. 239. 91–103. 2 indexed citations
3.
Hu, Yanan, et al.. (2023). Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD. Mediators of Inflammation. 2023. 1–15. 5 indexed citations
4.
Wu, Hao, et al.. (2023). Inflammatory bowel disease increases the levels of albuminuria and the risk of urolithiasis: a two-sample Mendelian randomization study. European journal of medical research. 28(1). 167–167. 9 indexed citations
6.
Li, Huan, et al.. (2023). Comprehensive analysis of differences in N6-methyladenosine RNA methylomes in Helicobacter pylori infection. Frontiers in Cell and Developmental Biology. 11. 1136096–1136096. 9 indexed citations
8.
Wu, Hao, Meihua Xu, Hong Hao, et al.. (2022). Examining endothelial function and carotid artery disease in patients with inflammatory bowel disease: a systematic review protocol. BMJ Open. 12(6). e059785–e059785. 1 indexed citations
9.
Liu, Xiaoming, et al.. (2022). Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study. Frontiers in Cellular and Infection Microbiology. 12. 903002–903002. 9 indexed citations
10.
Liu, Xiaoming, Yongqiang Zheng, Mengqing Xiao, et al.. (2022). SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis. Journal of Experimental & Clinical Cancer Research. 41(1). 353–353. 18 indexed citations
11.
Wu, Hao, Feng Chen, Xuanyou Liu, et al.. (2022). CagA+Helicobacter pylori, Not CagA–Helicobacter pylori, Infection Impairs Endothelial Function Through Exosomes-Mediated ROS Formation. Frontiers in Cardiovascular Medicine. 9. 881372–881372. 26 indexed citations
12.
Liu, Peng, Hao Wu, Huan Li, et al.. (2022). miR-21 antagonist alleviates colitis and angiogenesis via the PTEN/PI3K/AKT pathway in colitis mice induced by TNBS. Annals of Translational Medicine. 10(7). 413–413. 12 indexed citations
13.
Wu, Hao, et al.. (2022). Circulating exosomal miR-21 mediates HUVEC proliferation and migration through PTEN/PI3K/AKT in Crohn’s disease. Annals of Translational Medicine. 10(5). 258–258. 13 indexed citations
14.
Guo, Yinjie, et al.. (2022). Helicobacter pylori Infection Acts as an Independent Risk Factor for Intracranial Atherosclerosis in Women Less Than 60 Years Old. Frontiers in Cardiovascular Medicine. 8. 819315–819315. 7 indexed citations
15.
Gong, Renjie, Canxia Xu, Huan Li, & Xiaoming Liu. (2020). Polymerase chain reaction-based tests for detecting Helicobacter pylori clarithromycin resistance in stool samples: A meta-analysis. World Journal of Clinical Cases. 9(1). 133–147. 20 indexed citations
16.
Li, Huan, et al.. (2019). How doesHelicobacter pyloricause gastric cancer through connexins: An opinion review. World Journal of Gastroenterology. 25(35). 5220–5232. 11 indexed citations
17.
Chen, Zhiheng, Huan Li, Xiaoming Liu, et al.. (2019). Helicobacter pylori infection selectively increases the risk for carotid atherosclerosis in young males. Atherosclerosis. 291. 71–77. 36 indexed citations
18.
Li, Rong, et al.. (2017). Group 2 Innate Lymphoid Cells Are Involved in Skewed Type 2 Immunity of Gastric Diseases Induced by Helicobacter pylori Infection. Mediators of Inflammation. 2017. 1–12. 35 indexed citations
19.
Huang, Lihua, Canxia Xu, Xiaoming Liu, et al.. (2015). Expressional profiles of transcription factors in the progression of Helicobacter pylori-associated gastric carcinoma based on protein/DNA array analysis. Medical Oncology. 32(12). 265–265. 12 indexed citations
20.
Wang, Fen, Qian Feng, Zhiying Liu, et al.. (2014). The expression level of TRAF1 in human gastric mucosa is related to virulence genotypes ofHelicobacter pylori. Scandinavian Journal of Gastroenterology. 49(8). 925–932. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026